These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22079816)

  • 1. Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?
    Grasso G; Tomasello F
    World Neurosurg; 2012 Jan; 77(1):46-8. PubMed ID: 22079816
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin and subarachnoid hemorrhage.
    Grasso G; Sfacteria A
    J Neurosurg; 2010 Mar; 112(3):699-700. PubMed ID: 20192676
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage.
    Buemi M; Grasso G; Corica F; Calapai G; Salpietro FM; Casuscelli T; Sfacteria A; Aloisi C; Alafaci C; Sturiale A; Frisina N; Tomasello F
    Eur J Pharmacol; 2000 Mar; 392(1-2):31-4. PubMed ID: 10748269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of neurovascular protection of erythropoietin with age, sepsis, and statin therapy following aneurysmal subarachnoid hemorrhage.
    Tseng MY; Hutchinson PJ; Kirkpatrick PJ
    J Neurosurg; 2010 Jun; 112(6):1235-9. PubMed ID: 19929191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin for the treatment of subarachnoid hemorrhage: a review.
    Turner JD; Mammis A; Prestigiacomo CJ
    World Neurosurg; 2010 May; 73(5):500-7. PubMed ID: 20920933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin in Traumatic Brain Injury: An Answer Will Come Soon.
    Grasso G; Alafaci C; Buemi M
    World Neurosurg; 2015 Nov; 84(5):1491-2. PubMed ID: 26051375
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation and management of aneurysmal subarachnoid hemorrhage.
    Lasner TM; Raps EC
    Neuroimaging Clin N Am; 1997 Nov; 7(4):669-78. PubMed ID: 9336492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial nitric oxide-mediated Nrf2 activation as a novel mechanism for vascular and neuroprotection by erythropoietin in experimental subarachnoid hemorrhage.
    Genc S; Egrilmez MY; Genc K
    Med Hypotheses; 2006; 67(2):424. PubMed ID: 16707229
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietin: will it improve outcome after subarachnoid hemorrhage?
    Macdonald RL
    World Neurosurg; 2010 May; 73(5):463-4. PubMed ID: 20920924
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage.
    Alafaci C; Salpietro F; Grasso G; Sfacteria A; Passalacqua M; Morabito A; Tripodo E; Calapai G; Buemi M; Tomasello F
    Eur J Pharmacol; 2000 Oct; 406(2):219-25. PubMed ID: 11020484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and subarachnoid hemorrhage.
    Niemelä M; Niemi T; Hernesniemi J
    World Neurosurg; 2010 May; 73(5):461-2. PubMed ID: 20920923
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
    Springborg JB; Møller C; Gideon P; Jørgensen OS; Juhler M; Olsen NV
    Acta Neurochir (Wien); 2007 Nov; 149(11):1089-101; discussion 1101. PubMed ID: 17876497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system frontiers for the use of erythropoietin.
    Olsen NV
    Clin Infect Dis; 2003; 37 Suppl 4():S323-30. PubMed ID: 14582001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antifibrinolytic treatment in subarachnoid hemorrhage].
    Sunde NA; Bjerre PK
    Ugeskr Laeger; 2010 May; 172(19):1431. PubMed ID: 20470649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyclocaprone prevents early rebleeding after subarachnoid hemorrhage and should be administered already prior to transfer to the department of neurology].
    Astrup J
    Ugeskr Laeger; 2003 Feb; 165(7):697-8. PubMed ID: 12617051
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular targets for ameliorating early brain injury post subarachnoid hemorrhage: a new focus.
    Bhardwaj A
    Crit Care Med; 2010 Feb; 38(2):727-8. PubMed ID: 20083949
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage.
    Grasso G; Graziano F; Sfacteria A; Carletti F; Meli F; Maugeri R; Passalacqua M; Certo F; Fazio M; Buemi M; Iacopino DG
    Neurosurgery; 2009 Oct; 65(4):763-9; discussion 769-70. PubMed ID: 19834382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of early rebleeding.
    Schisano G; Nina P
    J Neurosurg; 2003 May; 98(5):1147-8; author reply 1148. PubMed ID: 12744387
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of early rebleeding.
    Roos Y; Vermeulen M
    J Neurosurg; 2003 May; 98(5):1148-9; author reply 1149-50. PubMed ID: 12744388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.